↓ Skip to main content

Short and long term effects of tibolone in postmenopausal women

Overview of attention for article published in this source, February 2012
Altmetric Badge

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
5 X users

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
93 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Short and long term effects of tibolone in postmenopausal women
Published by
John Wiley & Sons, Ltd, February 2012
DOI 10.1002/14651858.cd008536.pub2
Pubmed ID
Authors

Formoso, Giulio, Perrone, Enrica, Maltoni, Susanna, Balduzzi, Sara, D'Amico, Roberto, Bassi, Chiara, Basevi, Vittorio, Marata, Anna Maria, Magrini, Nicola, Maestri, Emilio

Abstract

Tibolone is an option available for the treatment of menopausal symptoms, based on short-term data on its efficacy. However, there is a need to consider the balance between the benefits and risks of tibolone as there are concerns about breast and endometrial cancer as well as stroke.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
France 1 1%
Australia 1 1%
Brazil 1 1%
Canada 1 1%
Spain 1 1%
United States 1 1%
Unknown 87 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 20 22%
Student > Master 11 12%
Other 10 11%
Student > Ph. D. Student 9 10%
Student > Bachelor 9 10%
Other 22 24%
Unknown 12 13%
Readers by discipline Count As %
Medicine and Dentistry 49 53%
Nursing and Health Professions 7 8%
Agricultural and Biological Sciences 6 6%
Psychology 5 5%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Other 9 10%
Unknown 13 14%